| 660248 |
ONCOTARGETS AND THERAPY |
Dramatic Responses of Recurrent Upper Urinary Tract Urothelial Carcinoma Harboring FGFR3 and TP53 Activating Mutations to Pembrolizumab in Combination with Erdafitinib: A Case Report |
2021-03-01 |
10.2147/ott.s297149 |
Ding Xinjia, Zong Jianguo, Li Xiang, Bai Xiaoyan, Tan Bowen, Sun Weibing, Wang Ruoyu, Ding Yan |
| 660247 |
ONCOTARGETS AND THERAPY |
Primary Tumor Radiotherapy During EGFR-TKI Disease Control Improves Survival of Treatment Naïve Advanced EGFR-Mutant Lung Adenocarcinoma Patients |
2021-03-01 |
10.2147/ott.s300267 |
Hsu Kuo-Hsuan, Huang Jing-Wen, Tseng Jeng-Sen, Chen Kuan-Wen, Weng Yih-Chyang, Yu Sung-Liang, Yang Tsung-Ying, Huang Yen-Hsiang, Chen Jeremy JW, Chen Kun-Chieh, Chang Gee-Chen |
| 660246 |
ONCOTARGETS AND THERAPY |
A Review of Chimeric Antigen Receptor T-Cell Therapy for Myeloma and Lymphoma |
2021-03-01 |
10.2147/ott.s242018 |
Atrash Shebli, Moyo Tamara K |
| 660245 |
ONCOTARGETS AND THERAPY |
Analysis of the Clinicopathological Characteristics of Stage I–III Colorectal Cancer Patients Deficient in Mismatch Repair Proteins |
2021-03-01 |
10.2147/ott.s278029 |
Liang Yichao, Cai Xinling, Zheng Xu, Yin Hongzhuan |
| 660244 |
ONCOTARGETS AND THERAPY |
miR-944 Suppresses EGF-Induced EMT in Colorectal Cancer Cells by Directly Targeting GATA6 |
2021-03-01 |
10.2147/ott.s290567 |
Tang JingTong, Gao Wei, Liu Gang, Sheng WeiWei, Zhou JianPing, Dong Qi, Dong Ming |
| 660243 |
ONCOTARGETS AND THERAPY |
LncRNA ANRIL Regulates Ovarian Cancer Progression and Tumor Stem Cell-Like Characteristics via miR-324-5p/Ran Axis [Retraction] |
2021-03-01 |
10.2147/ott.s312745 |
Wang Ke, Hu Yu-Bo, Zhao Ye, Ye Cong |
| 660242 |
ONCOTARGETS AND THERAPY |
PD-L1 Expression and Outcome in Patients with Metastatic Non-Small Cell Lung Cancer and EGFR Mutations Receiving EGFR-TKI as Frontline Treatment |
2021-03-01 |
10.2147/ott.s290445 |
Chang Cheng-Yu, Lai Yi-Chun, Wei Yu-Feng, Chen Chung-Yu, Chang Shih-Chieh |
| 660241 |
ONCOTARGETS AND THERAPY |
LncRNA LHFPL3-AS1 Promotes Oral Squamous Cell Carcinoma Growth and Cisplatin Resistance Through Targeting miR-362-5p/CHSY1 Pathway |
2021-03-01 |
10.2147/ott.s298679 |
Li Jiandong, Xu Xiaohu, Zhang Dandan, Lv Han, Lei Xin |
| 660240 |
ONCOTARGETS AND THERAPY |
Long Non-Coding RNA LINC00313 Accelerates Cervical Carcinoma Progression by miR-4677-3p/CDK6 Axis |
2021-03-01 |
10.2147/ott.s265007 |
Zhai Yongning, Liu Yang, Wang Zhen, Wang Wei, Zhou Juan, Lu Jingyuan |
| 660239 |
ONCOTARGETS AND THERAPY |
Case Report: SMARCB1 (INI-1)-Deficient Carcinoma of the Nasal Cavity with Pure Yolk Sac Tumor Differentiation and Elevated Serum AFP Levels |
2021-03-01 |
10.2147/ott.s302613 |
Li Chun-Yu, Han Ya-mei, Xu Ke, Wu Shu-yue, Lin Xu-Yong, Cao Hong-yi |
